investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Targeted Epigenetic Silencing of Oncogenic Transcription Factors (PQ18)
Pilar Blancafort
0 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Pilar Blancafort
University of Western Australia
Perth, Australia
Related projects
Aundrietta De Van Duncan
Understanding the Function of TRIM 24 in Mammary Epithelial Cells
Breast
Joyce M Slingerland
Effects of the PI3K Pathway on p27 Function and Cancer Progression
Breast
Jianmin Zhang
Hippo signaling pathway in breast cancer disparities: a translational approach
Breast
Ming Tan
Glucose Metabolism and ErbB2-Mediated Cancer Progression
Breast
Christopher H Contag
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
Breast
Ryan Alexander Flynn
CONTROL OF TRANSCRIPTION BY THE 7SK RNA IN BREAST CANCER
Breast
Hugh S. Gannon
Extraordinary responder cell lines reveal unique targetable genetic dependencies
Breast
Carol A Lange
Inducible PTK6 expression drives oncogenic signaling in breast cancer
Breast
James K Turkson
Salicylic Acid-Based Small-Molecule Stat3 Inhibitors for Anticancer Therapy
Breast
